ruchika, Editor, Medical Dialogues

Top

Dermatology

facebook
twitter

Sign in Signup

facebook
twitter

Sign in Signup

Medical Jobs
Medical Matrimony
MD Brand Connect
Corona Updates

Medical News
Health news
Medical Guidelines
AYUSH
State News
Medical Education
Industry

Sign In Register

Sign inRegister

Home
Medical news
Health news
Medical Guidelines
Medical Education
Industry
Case of the Day
Editorial

ruchika

Ruchika joined Medical Dialogue an Desk Editor for the Business Section in 2019. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home
ruchika

Articles By : ruchika

Zydus Cadila gets USFDA tentative nod to market Parkinson's disease drug

ruchika3 Aug 2020 4:30 AM GMT

Ahmedabad: Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules (US RLD - Rytary®) i...

US to put up $2.1 bn for Sanofi, GSK coronavirus vaccine

ruchika3 Aug 2020 4:15 AM GMT

Sanofi, based in France, and GSK of Britain said clinical trials with their vaccine should start in September, with a Phase 3 study under way by the...

FDA nod to Roche's Tecentriq plus Cotellic and Zelboraf in advanced melanoma

ruchika3 Aug 2020 4:00 AM GMT

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq® (atezolizumab) plus Cotellic® (cobimetinib) a...

Zydus Wellness net profit rises 11 per cent at Rs 89 crore in June quarter

ruchika2 Aug 2020 5:30 AM GMT

New Delhi: Zydus group firm Zydus Wellness on Friday reported a 10.94 per cent rise in consolidated net profit at Rs 89.20 crore for the quarter e...

Sanofi India reports net profit at Rs 136.3 crore in Q2

ruchika2 Aug 2020 3:45 AM GMT

Mumbai: Drug firm Sanofi India on Tuesday reported a net profit of Rs 136.3 crore for the second quarter ended June 30, 2020.The company had poste...

PharmaCyte Biotech submits Drug Master File to USFDA for Pancreatic Cancer Therapy

ruchika2 Aug 2020 3:30 AM GMT

Laguna Hills: PharmaCyte Biotech, Inc., a biotechnology company focused on developing cellular therapies for cancer and diabetes using its...

CDSCO panel recommends Serum Institute of India for phase 2, 3 human clinical trials of Oxford vaccine candidate

ruchika1 Aug 2020 6:25 AM GMT

New Delhi: A subject expert committee on COVID-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute o...

Tata Capital Growth Fund to invest Rs 225 crore in Biocon Biologics

ruchika1 Aug 2020 6:12 AM GMT

Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics, the biotechnology major added.

Advent International to acquire 60 percent stake in RA Chem Pharma

ruchika1 Aug 2020 4:00 AM GMT

They also said the PE Firm is acquiring up to 60 per cent stake in the pharmaceutical company.

Johnson and Johnson begins human safety trial for its COVID-19 vaccine candidate

ruchika1 Aug 2020 3:45 AM GMT

US: Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys t...

Torrent Pharma shares surge 13 per cent after Q1 earnings

ruchika1 Aug 2020 3:30 AM GMT

New Delhi: Shares of Torrent Pharmaceuticals rallied 13 per cent on Friday after the company reported a 48.61 per cent rise in its consolidated net pro...

Merck HIF-2α Inhibitor MK-6482 gets Breakthrough Therapy Designation from USFDA

ruchika31 July 2020 3:30 AM GMT

Kenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakt...

Powered By: Hocalwire

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok